NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/07/2025
Back to search
Official data from USPTO
ONE-STOP-SITE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ONE-STOP-SITE
ST13
US500000079295569Class
1, 5, 42
Filing
79295569
Registration
6458312
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
11/08/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
06/02/2020
Registration date
08/24/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/24/2021
Last transaction
11/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
IE
Examiner
SABLE, ERIC
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Hovione Scientia Limited
Representatives
R. Peter Spies DTL LIMITED
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Active chemical ingredients for use in the manufacture of pharmaceuticals for the preventiondiagnosistreatment or improvement of conditions and disordersinflammatoryallergicaloncologicaldegenerativegenetictraumatictumouralpressurepoisoningmutationsepsispsychiatricobeseeatingaddictivesexualsleepinfectious conditions and disordersbacterialviralfungal or parasitic conditions and disordersall of the above related to skinmusculo-skeletalcardiacneurologicalcellularvascularhematologicalrespiratorydigestivegenitalurinaryreproductivesensorialmetabolicendocrinelymphaticimmune or nervous systemsas well as pain managementfor use by humans or animals
Class 5
Compositions for medical and veterinarian usechemical products for pharmaceutical usechemical preparations for the preventiondiagnosistreatment or improvement of conditions and disordersinflammatoryallergicaloncologicaldegenerativegenetictraumatictumouralpressurepoisoningmutationsepsispsychiatricobeseeatingaddictivesexualsleepinfectious conditions and disordersbacterialviralfungal or parasitic conditions and disordersall of the above related to skinmusculo-skeletalcardiacneurologicalcellularvascularhematologicalrespiratorydigestivegenitalurinaryreproductivesensorialmetabolicendocrinelymphaticimmune or nervous systemsas well as pain managementfor use by humans or animals; diagnostic preparations for medical purposes; chemical products for pharmaceutical usechemical preparations for the preventiondiagnosistreatment or improvement of conditions and disordersinflammatoryallergicaloncologicaldegenerativegenetictraumatictumouralpressurepoisoningmutationsepsispsychiatricobeseeatingaddictivesexualsleepinfectious conditions and disordersbacterialviralfungal or parasitic conditions and disordersall of the above related to skinmusculo-skeletalcardiacneurologicalcellularvascularhematologicalrespiratorydigestivegenitalurinaryreproductivesensorialmetabolicendocrinelymphaticimmune or nervous systemsas well as pain managementfor use by humans or animals; pharmaceutical active ingredientssold as a component ingredient of pharmaceutical preparationspharmaceutical preparations and compoundsall of the foregoing for the preventiondiagnosistreatment or improvement of conditions and disordersinflammatoryallergicaloncologicaldegenerativegenetictraumatictumouralpressurepoisoningmutationsepsispsychiatricobeseeatingaddictivesexualsleepinfectious conditions and disordersbacterialviralfungal or parasitic conditions and disorders; all of the above related to skinmusculo-skeletalcardiacneurologicalcellularvascularhematologicalrespiratorydigestivegenitalurinaryreproductivesensorialmetabolicendocrinelymphaticimmune or nervous systemsas well as pain managementfor use by humans or animals
Class 42
Development of pharmaceutical products and drug products; research on pharmaceutical products and drug products; research and development of new products in the pharmaceutical industry; Consulting services in the field of design and development of engineering processes for the pharmaceutical industry; research and development services in the pharmaceutical field; research and development services in the field of pharmaceuticalschemical preparationsvaccinesmedicinesantibodiesnew products in the medical field
Publications
History of USPTO decisions and trademark events.
24 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/26/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/28/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/04/2022
FIMP
FINAL DISPOSITION PROCESSED
02/03/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/24/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/24/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/08/2021
PUBO
PUBLISHED FOR OPPOSITION
06/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/19/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/14/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/05/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/04/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/04/2021
RFNT
REFUSAL PROCESSED BY IB
11/29/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/06/2020
RFRR
REFUSAL PROCESSED BY MPU
11/05/2020
MAFR
APPLICATION FILING RECEIPT MAILED
10/20/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/16/2020
CNRT
NON-FINAL ACTION WRITTEN
10/15/2020
DOCK
ASSIGNED TO EXAMINER
10/14/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/14/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/08/2020
Continuous trademark protection
Get notified about every new filing that threatens ONE-STOP-SITE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.